Post-Gastric-Bypass Hypoglycemia Successfully Treated With Alpha-Glucosidase Inhibitor Therapy
Endocrine Practice, ISSN: 1530-891X, Vol: 19, Issue: 3, Page: 511-514
2013
- 17Citations
- 28Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations17
- Citation Indexes16
- 16
- CrossRef12
- Policy Citations1
- 1
- Captures28
- Readers28
- 28
Review Description
To review the effectiveness of alpha-gluco- sidase inhibitor (AGI) therapy in the treatment of hypoglycemia after Roux-en-y gastric surgery. Retrospective case review. Four patients who previously underwent Roux-en-y gastric bypass were evaluated because of severe symptomatic postprandial hypoglycemia that was unresponsive to a low-carbohydrate diet. Mixed-meal testing confirmed hyperinsulinemia. Other causes of hypoglycemia were ruled out by a combination of clinical examination, endocrine testing, and computed tomography imaging. Symptomatic hypoglycemia resolved in all 4 patients after AGI therapy was started. One patient could not tolerate long-term therapy because of a rash. The other 3 patients were followed for between 5 and 48 months and remained free of symptomatic postprandial hypoglycemia. AGI therapy is effective in the long-term treatment of post-Roux-en-y hypoglycemia in patients unresponsive to a low-carbohydrate diet. To our knowledge, this is the first report documenting the long-term usefulness of this therapy in a series of patients. (Endocr Pract. 2013;19:511-514)
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S1530891X20421524; http://dx.doi.org/10.4158/ep12281.ra; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84880101820&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/23337151; http://journals.aace.com/doi/abs/10.4158/EP12281.RA; http://aace.metapress.com/index/H30641131372108M.pdf; https://linkinghub.elsevier.com/retrieve/pii/S1530891X20421524; https://dx.doi.org/10.4158/ep12281.ra
AACE Corp (American Association of Clinical Endocrinologists)
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know